These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 24954628)
1. The effect of care setting in the delivery of high-value colon cancer care. Veenstra CM; Epstein AJ; Liao K; Morris AM; Pollack CE; Armstrong KA Cancer; 2014 Oct; 120(20):3237-44. PubMed ID: 24954628 [TBL] [Abstract][Full Text] [Related]
2. Hospital academic status and value of care for nonmetastatic colon cancer. Veenstra CM; Epstein AJ; Liao K; Griggs JJ; Pollack CE; Armstrong K J Oncol Pract; 2015 May; 11(3):e304-12. PubMed ID: 25901052 [TBL] [Abstract][Full Text] [Related]
3. The Value of Continuity between Primary Care and Surgical Care in Colon Cancer. Hussain T; Chang HY; Luu NP; Pollack CE PLoS One; 2016; 11(5):e0155789. PubMed ID: 27219454 [TBL] [Abstract][Full Text] [Related]
4. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer. Hussain T; Chang HY; Veenstra CM; Pollack CE J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063 [TBL] [Abstract][Full Text] [Related]
5. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670 [TBL] [Abstract][Full Text] [Related]
6. Fragmentation in specialist care and stage III colon cancer. Hussain T; Chang HY; Veenstra CM; Pollack CE Cancer; 2015 Sep; 121(18):3316-24. PubMed ID: 26043368 [TBL] [Abstract][Full Text] [Related]
7. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database. Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473 [TBL] [Abstract][Full Text] [Related]
9. The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study. Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Zhang S BMC Cancer; 2019 May; 19(1):418. PubMed ID: 31053096 [TBL] [Abstract][Full Text] [Related]
10. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries. Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321 [TBL] [Abstract][Full Text] [Related]
11. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. Kwan SW; Mortell KE; Hippe DS; Brunner MC J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308 [TBL] [Abstract][Full Text] [Related]
12. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients. Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739 [TBL] [Abstract][Full Text] [Related]
13. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. Gross CP; Andersen MS; Krumholz HM; McAvay GJ; Proctor D; Tinetti ME JAMA; 2006 Dec; 296(23):2815-22. PubMed ID: 17179458 [TBL] [Abstract][Full Text] [Related]
14. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men. Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397 [TBL] [Abstract][Full Text] [Related]
15. Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data. Cheng CY; Datzmann T; Hernandez D; Schmitt J; Schlander M Int J Cancer; 2021 Nov; 149(10):1744-1754. PubMed ID: 34213799 [TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 Radioembolization Is Cost Effective in Intrahepatic Cholangiocarcinoma: A SEER Medicare Population Study. Ghodadra A; Xing M; Zhang D; Kim HS J Vasc Interv Radiol; 2019 Mar; 30(3):293-297. PubMed ID: 30819468 [TBL] [Abstract][Full Text] [Related]
17. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010 [TBL] [Abstract][Full Text] [Related]
18. Hospital lymph node examination rates and survival after resection for colon cancer. Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198 [TBL] [Abstract][Full Text] [Related]
19. Provider treatment intensity and outcomes for patients with early-stage bladder cancer. Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919 [TBL] [Abstract][Full Text] [Related]
20. Readmissions After Colon Cancer Surgery: Does It Matter Where Patients Are Readmitted? Luu NP; Hussain T; Chang HY; Pfoh E; Pollack CE J Oncol Pract; 2016 May; 12(5):e502-12. PubMed ID: 27048614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]